Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Shape Therapeutics
Biotech
MBX Biosciences, MaaT Pharma and more—Chutes & Ladders
Metabolic disorder biotech lands industry vet as CMO. MaaT welcomes ex-Autolus leader. Former Seagen execs take Shape.
Gabrielle Masson
,
Andrea Park
Jun 28, 2024 8:30am
Phenomic inks 2nd deal in 2 days, Shape adds to Roche pact
Nov 30, 2023 10:14am
Otsuka eye disease strategy takes Shape with $1.5B biobucks deal
Sep 8, 2023 8:45am
Fierce Biotech's 2022 Fierce 15
Sep 12, 2022 3:00am
Improving RNA editing by recruiting the body's natural protein
Feb 14, 2022 9:28am
Roche's gene therapy plans take Shape with $3B-plus deal
Aug 24, 2021 11:05am
